LeonaBio (LONA) Total Liabilities (2019 - 2026)

LeonaBio (LONA) has 8 years of Total Liabilities data on file, last reported at $22.3 million in Q1 2026.

• On a quarterly basis, Total Liabilities rose 260.46% year-over-year to $22.3 million in Q1 2026; TTM through Mar 2026 was $22.3 million, a 260.46% increase from a year earlier, with the FY2025 full-year figure at $64.4 million, up 361.77% from the prior year.
• Total Liabilities for Q1 2026 stood at $22.3 million, down from $64.4 million in the prior quarter.
• Over the last five years, Total Liabilities for LONA reached as high as $64.4 million in Q4 2025 and fell as low as $3.2 million in Q3 2025.
• Historically, Total Liabilities has averaged $21.1 million across 5 years, with a median of $22.3 million in 2026.
• On a YoY basis, Total Liabilities climbed as much as 361.77% in 2025 and fell as far as 88.67% in 2025.
• Year by year, Total Liabilities stood at $23.0 million in 2022, then jumped by 30.59% to $30.1 million in 2023, then slumped by 53.63% to $13.9 million in 2024, then jumped by 361.77% to $64.4 million in 2025, then plunged by 65.37% to $22.3 million in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $22.3 million in Q1 2026, $64.4 million in Q4 2025, and $3.2 million in Q3 2025.